It has been pointed out that HIF-1α can also activate a variety of pathways that enhance tumor cell resistance.[38] And HIF-1α is at the core of tumor metabolic reprogramming, which speculates that understanding HIF-1α is the key to understanding tumor drug resistance and developing chemotherapeutic drugs. Here, HIF1A is linked to neoplasm.